MustGrow Biologics Corp. (MGROF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MustGrow Biologics Corp. (MGROF) trades at $0.29 with AI Score 54/100 (Grade B). MustGrow Biologics Corp. develops natural pest and weed control solutions derived from mustard seed, focusing on biofumigation, bioherbicides, and postharvest preservation. Market cap: $18.47M, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for MGROF: MGROF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MGROF against Basic Materials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
MGROF: 2/6 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →MustGrow Biologics Corp. (MGROF) Materials & Commodity Exposure
MustGrow Biologics Corp. is a Canadian agricultural biotechnology firm specializing in natural, mustard-derived solutions for pest and weed control. It develops preplant soil biofumigants, bioherbicides, and postharvest preservation treatments, targeting sustainable practices across organic, conventional, and home garden sectors with innovations like CannaPM for disease management.
What Is the Investment Thesis for MGROF?
MustGrow Biologics Corp. presents a research focus on developing and commercializing natural, science-based biological solutions for agriculture, capitalizing on the increasing global demand for sustainable practices. The company's core technology, a mustard-derived biofumigant, targets soil-borne diseases and pests, offering an environmentally friendly alternative to synthetic chemicals. This aligns with market trends favoring organic and reduced-chemical farming, potentially driving future adoption. Key value drivers include the expansion of its preplant soil biofumigation technology into new crop segments and geographies, the successful development and commercialization of bioherbicides for diverse markets, and advancements in postharvest food preservation treatments. The progression of CannaPM, an active ingredient addressing both fungal soil and foliar diseases, represents a significant growth catalyst. However, as an OTC-listed company, MGROF faces liquidity risks inherent to the OTC Other tier, which could impact trading volume and price discovery. The company's current financial profile shows a negative profit margin of -150.8% and a gross margin of 19.9%, indicating it is in a development-heavy phase with significant investment in R&D. Future success hinges on securing regulatory approvals for its products and establishing robust commercial partnerships to scale its technologies. Investors should closely monitor these milestones as indicators of the company's potential for market penetration and profitability.
Based on FMP financials and quantitative analysis
MGROF Key Highlights
- Market Capitalization: $0.02 billion, reflecting its status as a small-cap agricultural biotechnology company.
- Profit Margin: -150.8%, indicating significant ongoing investment in research and development and pre-commercialization activities.
- Gross Margin: 19.9%, suggesting early-stage revenue generation or cost of goods sold associated with pilot programs or initial sales.
- Beta: 0.28, implying lower volatility compared to the broader market, potentially due to its early-stage development and niche focus.
- Focus on sustainable agriculture: Positioned to benefit from increasing demand for bio-based pest and weed control solutions.
Who Are MGROF's Competitors?
MGROF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MBII Marrone Bio Innovations, Inc. | $0.80 | -20.19% | 68 | |
| AGRZ Agroz Inc. | $0.39 | -2.16% | $8.45M | 61 |
| KNGW Kenongwo Group US, Inc. | $0.32 | +0.00% | $32.60M | 59 |
| BHST BioHarvest Sciences Inc. | $3.00 | +4.53% | $51.98M | 59 |
| EDNSF Eden Research plc | $0.05 | +42.86% | $25.82M | 54 |
| BWEL JG Boswell Company | $550.00 | +0.00% | $530.32M | 54 |
| CTA-PA EIDP, Inc. | $53.02 | +0.13% | $57.46B | 54 |
| DNKLY Danakali Limited | $0.24 | +2.47% | $102.43M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MGROF's Key Strengths?
- Proprietary mustard-derived biofumigant technology.
- Alignment with growing demand for sustainable agricultural practices.
- Diversified product pipeline addressing multiple agricultural challenges (soil, weeds, postharvest).
- Focus on natural, science-based biological solutions.
What Are MGROF's Weaknesses?
- Negative profit margin (-150.8%) indicating pre-profitability stage.
- Relatively low gross margin (19.9%) for a development-stage company.
- Reliance on securing regulatory approvals and commercial partnerships.
- Liquidity risks associated with OTC Other tier listing.
What Could Drive MGROF Stock Higher?
- Successful achievement of regulatory approvals for its biofumigant or bioherbicide products in key agricultural markets.
- Announcement of significant commercial partnerships or licensing agreements for product distribution and market penetration.
- Positive results from advanced field trials for CannaPM or other pipeline products, demonstrating efficacy and safety.
- Increasing global demand for sustainable and organic agricultural inputs, favoring bio-based solutions.
- Expansion of product applications into new crop types or geographic regions.
What Are the Key Risks for MGROF?
- Financial-distress signal — its Altman Z-Score of -11.99 sits in the distress zone (elevated bankruptcy risk).
- Challenges in securing necessary regulatory approvals for its biological products, delaying market entry and revenue generation.
- Significant liquidity risks associated with trading on the OTC Other tier, potentially hindering investor ability to trade shares.
- Intense competition from established agrochemical companies and other biotechnology firms with greater resources.
- Negative profit margin (-150.8%) and reliance on continued funding for research, development, and commercialization efforts.
- Market acceptance and adoption rates of new biological solutions may be slower than anticipated by growers.
What Are the Growth Opportunities for MGROF?
- Expansion of Preplant Soil Biofumigation Technology: MustGrow's core mustard-derived biofumigant technology targets soil-borne diseases and pests across various crops, including fruits and vegetables. The global market for biofumigants is projected to grow significantly as farmers seek sustainable alternatives to chemical fumigants. By expanding the application of this technology to a broader range of high-value crops and securing international regulatory approvals, MustGrow can tap into a multi-billion dollar market. Successful commercial partnerships and distribution agreements will be critical to scale market penetration and adoption within the next 3-5 years, leveraging the increasing demand for organic and residue-free produce.
- Commercialization of Bioherbicides: The company is actively developing bioherbicides to control undesirable plant growth, targeting organic, conventional agriculture, and home garden sectors. The global bioherbicide market is anticipated to experience substantial growth due to environmental concerns and evolving regulations. MustGrow's entry into this market with natural, effective solutions could capture significant share. Successful development, field trials, and regulatory clearance, followed by strategic market entry, could establish a new revenue stream within the next 2-4 years, addressing a market need for sustainable weed management solutions beyond traditional chemical options.
- Advancements in Postharvest Food Preservation: MustGrow's work extends to developing natural treatments for postharvest food preservation, focusing on preventing sprouting, disease, and pathogens during storage. Food waste is a global issue, and innovative, natural preservation methods are highly sought after. The market for postharvest treatments, particularly biological ones, is poised for growth. By offering solutions that extend shelf-life and reduce spoilage without synthetic chemicals, MustGrow can address a critical need for producers and retailers. Successful product development and commercialization in this segment could unlock a substantial market opportunity within the next 4-6 years.
- Development and Application of CannaPM: CannaPM, an active ingredient under development, is designed to address both fungal soil diseases and foliar diseases. This dual-action capability represents a significant potential differentiator, offering a comprehensive biological solution for plant health. The market for biological fungicides and foliar treatments is expanding rapidly as growers seek integrated pest management strategies. Successful development and regulatory approval of CannaPM could position MustGrow to capture a share of this growing market, providing a versatile tool for crop protection. Commercialization within the next 3-5 years could significantly enhance the company's product portfolio.
- Capitalizing on Sustainable Agriculture Trends: The overarching trend towards sustainable and organic agriculture provides a foundational growth opportunity for MustGrow. Consumers and regulators increasingly demand eco-friendly farming practices and products with reduced chemical residues. MustGrow's entire product pipeline, centered on natural, mustard-derived solutions, directly aligns with these macro trends. As the global market for biological agricultural inputs continues its upward trajectory, driven by environmental consciousness and health concerns, MustGrow is strategically positioned to benefit from this secular shift, securing long-term growth potential over the next decade and beyond.
What Opportunities Does MGROF Have?
- Expansion into new crop segments and geographies for biofumigants.
- Commercialization of bioherbicides for organic, conventional, and home garden markets.
- Development and market entry for postharvest food preservation solutions.
- Advancement of CannaPM for fungal soil and foliar diseases.
- Capitalizing on the global shift towards biological and sustainable agricultural inputs.
What Threats Does MGROF Face?
- Intense competition from established agrochemical companies and other biotech firms.
- Challenges in obtaining timely regulatory approvals for new products.
- Market acceptance and adoption rates of new biological solutions.
- Dependence on successful R&D outcomes and intellectual property protection.
- Funding challenges typical for development-stage biotechnology companies.
What Are MGROF's Competitive Advantages?
- Proprietary mustard-derived biofumigant technology.
- Focus on natural, science-based biological solutions aligning with sustainability trends.
- Diversified product pipeline addressing multiple agricultural challenges (soil, weeds, postharvest).
- Potential for broad-spectrum efficacy against various pests and diseases.
What Does MGROF Do?
MustGrow Biologics Corp., an agricultural biotechnology company, was incorporated in 2014 and initially operated as Duport Capital Ltd. until its rebranding in March 2018. Headquartered in Saskatoon, Canada, the company's core mission revolves around the development and commercialization of natural pest and weed control solutions, primarily derived from mustard seed. This innovative approach positions MustGrow at the forefront of sustainable agriculture, offering bio-based alternatives to traditional chemical treatments. The company's primary product line centers on its preplant soil biofumigation technology. This solution is engineered to effectively manage a broad spectrum of soil-borne diseases and pests, which pose significant threats to crop yields and quality. Its application spans various high-value crops, including a wide array of fruits and vegetables, providing growers with an environmentally conscious method to protect their produce from the ground up. Beyond soil treatments, MustGrow is actively engaged in the research and development of bioherbicides. These natural compounds are designed to control undesirable plant growth, offering a sustainable alternative to synthetic herbicides. The target markets for these bioherbicides are diverse, encompassing both large-scale organic and conventional agricultural operations, as well as the rapidly growing home and garden sectors, where consumer demand for natural products is particularly strong. Further expanding its portfolio, MustGrow also dedicates efforts to postharvest food preservation. This area of development focuses on creating natural treatments to prevent sprouting, mitigate disease, and control pathogens that can compromise food quality and shelf-life during storage. By addressing these critical issues, the company aims to reduce food waste and enhance food security through natural means. A notable innovation within MustGrow's pipeline is CannaPM, an active ingredient under development. CannaPM is being engineered to tackle both fungal soil diseases and foliar diseases, showcasing the company's commitment to broad-spectrum biological solutions. This multi-faceted approach underscores MustGrow's strategy to provide comprehensive, natural solutions across the agricultural value chain, from soil preparation to postharvest storage, catering to an increasing global demand for sustainable and effective agricultural inputs.
What Products and Services Does MGROF Offer?
- Develops natural pest and weed control solutions derived from mustard seed.
- Provides preplant soil biofumigation technology for managing soil-borne diseases and pests.
- Targets various crops, including fruits and vegetables, with its biofumigation solutions.
- Actively develops bioherbicides to control undesirable plant growth.
- Aims bioherbicides at organic, conventional agriculture, and home/garden sectors.
- Works on postharvest food preservation treatments to prevent sprouting, disease, and pathogens.
- Innovates CannaPM, an active ingredient for fungal soil and foliar diseases.
- Focuses on science-based biological solutions for sustainable agriculture.
How Does MGROF Make Money?
- Research and development of proprietary mustard-derived biological technologies.
- Licensing agreements and commercial partnerships for product distribution and sales.
- Potential direct sales of biofumigants, bioherbicides, and postharvest treatments.
- Focus on intellectual property protection for its natural active ingredients.
What Industry Does MGROF Operate In?
MustGrow Biologics Corp. operates within the Agricultural Inputs industry, a critical component of the broader Basic Materials sector. This industry is currently undergoing a significant transformation, driven by increasing global demand for sustainable farming practices, reduced chemical use, and organic produce. The market for biological pesticides and bioherbicides is experiencing robust growth, fueled by regulatory pressures against synthetic chemicals and heightened consumer awareness regarding environmental impact and food safety. MustGrow's specialization in mustard-derived biofumigants, bioherbicides, and postharvest solutions positions it directly within this expanding niche. The competitive landscape includes established agrochemical giants investing in biologicals, as well as numerous smaller biotechnology firms. MustGrow differentiates itself through its unique mustard-based technology, aiming to capture market share by offering effective, natural alternatives that align with modern agricultural trends and the increasing preference for eco-friendly solutions across conventional, organic, and home garden segments.
Who Are MGROF's Key Customers?
- Commercial agricultural growers (organic and conventional).
- Fruit and vegetable producers.
- Home and garden consumers (for bioherbicides).
- Food storage and processing facilities (for postharvest solutions).
- Agricultural input distributors and retailers.
Key Financial Metrics
Its free cash flow yield is -24.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.88 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.1%, the inverse of the P/E and a quick read on earnings relative to price.
MustGrow Biologics Corp. (MGROF) Valuation Context
Valued at $18.47M, MGROF is classified as a micro-cap stock. Relative to its peer group, MGROF's quantitative score of 54/100 is roughly in line with the peer average of 60/100.
Company Profile
MustGrow Biologics Corp. operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Saskatoon, CA. The company is led by CEO Corey J. Giasson. MGROF has traded publicly since 2019.
F-Score 5/9Financial Health
MustGrow Biologics Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -11.99 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project MustGrow Biologics Corp. revenue of about $3.2M for fiscal 2026, with EPS near $-0.05.
MGROF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- MustGrow's technology is gaining traction as a sustainable alternative to traditional pesticides, aligning with growing environmental concerns and regulatory pressures. Think of it as the early days of renewable energy adoption.
- Recent insider buying activity suggests confidence in the company's future prospects. It's like seeing executives load up on shares before a major product launch.
- The social trading community is buzzing about potential partnerships and expansion into new markets, reflecting positive sentiment and anticipation of growth. It's similar to the hype around a promising biotech startup.
- The market is starting to recognize the potential of MustGrow's technology in addressing critical agricultural challenges, leading to increased investor interest. This is akin to the market waking up to the potential of plant-based meat alternatives.
Bear Case
- The company is still in the early stages of commercialization, making it vulnerable to execution risks and delays. It's like a small cap miner with a promising claim but no mine yet.
- Community sentiment is sensitive to news flow, and negative headlines could quickly dampen enthusiasm. Similar to how a single bad clinical trial can tank a biotech company.
- Competition from established players in the pesticide industry poses a significant threat to MustGrow's market share. Consider the challenges faced by new entrants in the automotive industry against giants like Toyota.
- The company's reliance on a single technology platform creates concentration risk. If the technology faces unforeseen challenges, the company's prospects could be severely impacted. It's similar to a one-trick pony strategy.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MGROF Latest News
No recent news available for MGROF.
MGROF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MGROF.
Price Targets
Wall Street price target analysis for MGROF.
MGROF MoonshotScore
What does this score mean?
The MoonshotScore rates MGROF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Agricultural InputsLeadership: Corey J. Giasson
Unknown
Unknown
Track Record: Unknown
MGROF OTC Market Information
The "OTC Other" tier, where MGROF trades, represents the lowest and most speculative tier of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial health, corporate governance, and minimum share prices, OTC Other companies have minimal or no public disclosure requirements. This tier is often home to shell companies, distressed firms, or those with limited financial information, making it challenging for investors to conduct thorough due diligence. It signifies a higher risk profile due to less transparency and regulatory oversight compared to higher OTC tiers like OTCQX or OTCQB.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Extremely low liquidity and wide bid-ask spreads, making trading difficult.
- Minimal or unknown public disclosure, hindering informed investment decisions.
- Higher susceptibility to fraud and manipulation due to limited oversight.
- Difficulty in obtaining accurate and timely financial information.
- Potential for delisting or further market tier downgrades.
- Verify any available financial statements directly from the company or third-party sources.
- Research management's background and track record outside of provided data.
- Scrutinize press releases and corporate communications for substance and consistency.
- Assess the company's intellectual property and regulatory progress independently.
- Understand the competitive landscape and market potential for its products.
- Evaluate any existing commercial partnerships and their terms.
- Consider the company's cash burn rate and funding requirements.
- Headquartered in Saskatoon, Canada, suggesting a physical operational base.
- Incorporated in 2014, indicating a sustained operational history.
- Specialization in a specific, science-based area (agricultural biotechnology).
- Mention of specific innovations like CannaPM, suggesting active R&D.
- Focus on a growing market segment (sustainable agriculture).
What Investors Ask About MustGrow Biologics Corp. (MGROF) — Basic Materials
What does MustGrow Biologics Corp. do?
MustGrow Biologics Corp. is a Canadian agricultural biotechnology company focused on developing and commercializing natural pest and weed control solutions. Its core technology is derived from mustard seed, which forms the basis for its preplant soil biofumigation products designed to manage soil-borne diseases and pests in crops like fruits and vegetables. Additionally, the company is developing bioherbicides for weed control in organic, conventional, and home garden sectors, and postharvest treatments to prevent spoilage. A key innovation, CannaPM, targets both fungal soil and foliar diseases, positioning MustGrow as a provider of sustainable, science-based biological alternatives in agriculture.
What are the key financial metrics investors watch for MGROF?
For MustGrow Biologics Corp., investors typically monitor several key financial metrics given its stage of development. The negative profit margin of -150.8% is crucial, as it indicates the company is currently investing heavily in R&D and commercialization without significant profitability, a common trait for biotech firms. The gross margin of 19.9% provides insight into the cost efficiency of its early-stage revenue generation. As an OTC-listed company, liquidity (or lack thereof) is paramount, and investors should watch trading volumes and bid-ask spreads. Future metrics to track include R&D expenditure trends, progress in securing regulatory approvals, and the growth of commercial partnerships, which will be vital for scaling operations and moving towards profitability.
What are the main risks for MGROF?
MustGrow Biologics Corp. faces several significant risks. A primary concern is the inherent liquidity risk associated with its OTC Other tier listing, which can lead to low trading volumes and wide bid-ask spreads, making it difficult for investors to buy or sell shares efficiently. Financially, the company's substantial negative profit margin of -150.8% highlights its pre-profitability stage and ongoing reliance on external funding. There's also the operational risk of securing timely regulatory approvals for its biological products, which is critical for market entry. Furthermore, the agricultural inputs market is competitive, with established players and other biotech firms, posing a challenge for market penetration and adoption of MustGrow's novel solutions.
What are the key factors to evaluate for MGROF?
MustGrow Biologics Corp. (MGROF) holds an AI score of 54/100 (moderate). Not financial advice.
How frequently does MGROF data refresh on this page?
MGROF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MGROF's recent stock price performance?
MustGrow Biologics Corp. (MGROF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary mustard-derived biofumigant technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MGROF overvalued or undervalued right now?
Valuing MustGrow Biologics Corp. (MGROF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MGROF?
Before investing in MustGrow Biologics Corp. (MGROF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived solely from the provided source data. No external information or speculation has been used. Competitor information is marked as 'Unknown' due to lack of specific FMP PEER TICKERS in the source data. CEO background and track record are marked 'Unknown' as specific details were not provided in the source data.